PureTech

是其中之一......

• FTSE 350;
• TOB Iconic 10,000.

PureTech 是一家在股票代码 PRTC (US) 下上市的公司。

他们在：

• 生物技术67%
• 健康33%

查看带有其 49 名主要高管的组织结构图

PureTech 搜索最多的简介

• Bharatt Chowrira, Chief Executive Officer
• Sharon Barber-Lui, Director
• Kiran Mazumdar-Shaw, Director

高管在PureTech变化

• Michele HolcombMichele Holcomb 将于202411月22作为 Independent Non-Executive Director 加入公司  (新闻发布的2024八月22号).
• David Wheadon已作为Director加入公司  (新闻发布的2024八月14号).
• Raju Kucherlapati 曾任 Interim Chairman of the Board, 现升职为 Chairman of the Board  (新闻发布的2024六月20号).

更多的变化在％s

创建提醒
跟踪 PureTech 的高管变动

PureTech 拥有 2,317 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。

Popular M&A news in 生物技术

• AgomAb Therapeutics 刚刚宣布为 89 筹款数百万美元。 (公布2024十月29号).
• Seaport Therapeutics 刚刚宣布为 225 筹款数百万美元。 (公布2024十月25号).
• TuHura Biosciences and Kintara Therapeutics have merged  (公布2024十月20号)..

生物技术 行业的其他推荐联系人

• Scholar Rock 企业 Kristina Burow - Director
• UroGen 企业 Fred Cohen - Director
• Adaptimmune Therapeutics 企业 Ali Behbahani - Non-Executive Director

了解更多有关生物技术行业的信息 >

PureTech 的最新新闻稿

• Notice of Half-Yearly Results | PureTech Health
• PureTech Founded Entity Akili Announces Phase 3 Study of Digital Treatment in Children with ADHD Begun by Shionogi in Japan | PureTech Health
• PureTech Founded Entity Akili Announces the Journal Lupus Publishes Investigator-Initiated Study Results Demonstrating Improved Executive Function in Patients with Systemic Lupus Erythematosus Following Use of AKL-T01 Product Candidate | PureTech Health
• PureTech Founded Entity Akili Announces Public Company Board of Director Nominees | PureTech Health
• PureTech Initiates Late-Stage Clinical Study of Wholly-Owned Candidate LYT-100 (Deupirfenidone) in IPF and Advances LYT-200 (Anti-Galectin-9 mAb) | PureTech Health
• PureTech Founded Entity Vedanta Biosciences Unveils State-of-the-Art Manufacturing Facility to Provide Clinical and Commercial Supply of Oral Therapies Based on Defined Bacterial Consortia | PureTech Health
• PureTech News | PureTech Health
• PureTech Founded Entity Gelesis Announces Additional $15 Million Pre-Order for Plenity®, Bringing Total Pre-Paid Orders from Ro for Plenity to $55 Million | PureTech Health
• Results of Annual General Meeting | PureTech Health
• PureTech Reports Results from Phase 2 Study of LYT-100-COV in Post-Acute "Long" COVID with Respiratory Complications | PureTech Health
• View more press releases Close

关于 PureTech 的社交媒体

• PureTech 在 维基百科、谷歌新闻 和 雅虎财经
• PureTech 在 LinkedIn、叽叽喳喳 和 YouTube

通过电子邮件联系联系该企业高管，包括 Sharon Barber-Lui

致电PureTech，电话：+1 617...

查看组织结构图

Register to receive your alert

报告错误